Fifty 410 tirzepatide review
$1,596 a year, all in. That is $96 more than the cheapest option. Prepaid blocks with no subscription.
Updated 2026-09-18 · every price checked by hand
How we make money: one company on this page — Coreage Rx — pays us a commission when a reader signs up through our link. It buys them nothing else: not a better score, not a higher place in the table, not the removal of a single criticism. Our scoring method and full disclosure are both public.
$399 buys three months of compounded tirzepatide — $133 a month — with no subscription and nothing to cancel.
Higher doses use the $549 block instead, or $183 a month. Over a year that is roughly $1,596 to $2,196 depending on which protocol you settle on.
The yearly bill
| Fifty 410 · tirzepatide | |
|---|---|
| Advertised from | $133/mo |
| Membership on top | None |
| What you actually pay | $133/mo |
| Over twelve months | $1,596 |
| Versus the cheapest option | +$96 a year |
| Cheapest-first position | 4 of 18 |
Sold only as prepaid three-month blocks: $399 for the starter protocol or $549 for high-dose. There is no month-to-month option.
Where the money goes
The block covers medication, provider consultation and free one-to-two-day shipping. No membership, no recurring charge, no auto-renewal — you buy it outright and it ends.
Compounded GLP-1 telehealth platform selling prepaid three-month blocks with no membership, no subscription and no recurring charges.
What the same money buys elsewhere
Trimi at about $1,500 a year and Ozari at $1,500 on the starter comparison. Fifty 410 is competitive at the starter protocol and less so once you move to high dose.
| Programme | Per month | Per year | Extra vs cheapest |
|---|---|---|---|
| Coreage Rx Cheapest no membership fee | $199 | $2,388 | +$888 |
| Trimi no membership fee | $125 | $1,500 | — |
| Ozari Health no membership fee | $125 | $1,500 | — |
| Fifty 410 no membership fee | $133 | $1,596 | +$96 |
| PlexusDx no membership fee | $189 | $2,268 | +$768 |
| Ivím Health no membership fee | $199 | $2,388 | +$888 |
Is the extra worth it?
The anti-subscription model is worth something real if you have been burned by auto-renewals. The catch is you cannot try one month — blocks only.
What we checked
- Compounded tirzepatide starter protocol at $133/month, sold as a $399 three-month block.
- High-dose tirzepatide protocol at $183/month, sold as a $549 three-month block.
- No membership, no subscription and no recurring charges — you buy a block outright.
- Provider consultation and free 1-2 day shipping included in the price.
- States it is a telehealth platform that does not compound or distribute medication itself, and that preparations come from FDA-registered 503A pharmacies.
- Publishes unusually detailed information on 503A standards, USP 797 sterility and batch testing.
- No payment taken unless a provider approves you.
Verified 2026-09-18. Prices in this market move, so treat anything older than a month as a starting point rather than a quote.
The good
- Genuinely no subscription — you buy a block and nothing recurs.
- Among the lowest tirzepatide rates verified.
- Unusually detailed public explanation of 503A standards and batch testing.
- No payment taken until a provider approves you.
The bad
- Prepaid blocks only, so there is no way to try a single month.
- Higher doses cost meaningfully more — $183/month against $133.
- Does not name the specific pharmacy, only the standards it requires.
Watch for this at checkout. The $133 is the starter protocol. Moving to the high-dose protocol takes it to $183/month, and both are prepaid three-month commitments.
Verdict
Cheap, clean and commitment-light in the ways that matter. Budget for $183, not $133, because most people titrate up.
Full workings for every programme are in the cheapest tirzepatide programmes, and our scoring is explained on how we rate.